Infant Bacterial Therapeutics AB (publ) (IBT-B) — Tangible Net Worth Ratio
Infant Bacterial Therapeutics AB (publ) (IBT-B) has a Tangible Net Worth Ratio of 93.3% as of September 2025. This metric is calculated by deducting intangible assets (Skr8.27 Million) from net assets (Skr124.36 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See IBT-B working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Infant Bacterial Therapeutics AB (publ) Tangible Net Worth Ratio (2013–2024)
This chart shows how Infant Bacterial Therapeutics AB (publ)'s Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 93.3%, reflecting net assets of Skr124.36 Million with intangible assets of Skr8.27 Million SEK. See IBT-B days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Infant Bacterial Therapeutics AB (publ) (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Infant Bacterial Therapeutics AB (publ) from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Infant Bacterial Therapeutics AB (publ) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 94.8% | Skr170.26 Million | Skr8.89 Million | Skr239.57 Million | ▼ -2.0 pp |
| 2023 | 96.8% | Skr305.15 Million | Skr9.70 Million | Skr351.33 Million | ▼ 0.0 pp |
| 2022 | 96.8% | Skr331.71 Million | Skr10.52 Million | Skr349.62 Million | ▼ -0.3 pp |
| 2021 | 97.1% | Skr395.25 Million | Skr11.33 Million | Skr408.48 Million | ▼ -0.1 pp |
| 2020 | 97.2% | Skr440.15 Million | Skr12.15 Million | Skr450.32 Million | ▼ -0.2 pp |
| 2019 | 97.5% | Skr510.40 Million | Skr12.97 Million | Skr518.27 Million | ▼ -0.1 pp |
| 2018 | 97.5% | Skr556.72 Million | Skr13.78 Million | Skr563.37 Million | ▲ +6.2 pp |
| 2017 | 91.3% | Skr168.37 Million | Skr14.60 Million | Skr175.02 Million | ▲ +6.0 pp |
| 2016 | 85.4% | Skr105.23 Million | Skr15.41 Million | Skr110.11 Million | ▲ +7.0 pp |
| 2015 | 78.3% | Skr74.81 Million | Skr16.23 Million | Skr82.54 Million | ▲ +33.4 pp |
| 2014 | 44.9% | Skr11.03 Million | Skr6.08 Million | Skr14.54 Million | ▼ -55.1 pp |
| 2013 | 100.0% | Skr1.05 Million | Skr0.00 | Skr1.29 Million | — |